Methotrexate and psoriasis in the era of new biologic agents.
Saporito
Frank C
FC
Baylor University Medical Center, Dallas, Texas 75230, USA.
Menter
M Alan
MA
D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000473:pathology; D003131:Combined Modality Therapy; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D011565:Psoriasis / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology
D003879:Dermatologic Agents; D008727:Methotrexate